This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Huge Data Volumes Boost Adoption Of Business Analytics In Asia-Pacific's Healthcare Sector, Finds Frost & Sullivan

SINGAPORE, Jan. 9, 2013 /PRNewswire/ -- Mounting volumes of medical and healthcare data have spurred healthcare providers in Asia-Pacific to adopt business analytics applications. To manage this data, healthcare providers are looking to partner with local and global software vendors. As a result, the emerging business analytics market in the region is poised for steady growth.

New analysis from Frost & Sullivan (, APAC Business Analytics for Healthcare Providers—Market Opportunity Assessment, finds that the market earned revenues of over $315.9 million in 2011 and estimates this to reach $654.2 million in 2018. The healthcare industry is becoming increasingly service-oriented, with the balance of power shifting from medical professionals in favor of consumers.

To identify sustainable competitive advantages and derive insights from enterprise resource planning tools, customer satisfaction surveys, and clinical information systems, service providers are turning to business analytics.

"In addition, effective analytics and intelligence tools are necessary to mine and analyze the large pool of data available in healthcare organizations especially as healthcare providers in Asia-Pacific adopt EHR programs," said Frost & Sullivan Research Analyst Natasha Gulati. "Efficient analysis improves patient care, reduces medical error, assists in prognosis, helps predict medical outcomes, and improves profitability."

It is crucial for medical and health professionals in Asia-Pacific to develop IT skills. Currently, IT professionals struggle to manage complex business analytics solutions and medical professionals are unable to leverage these solutions to their full advantage. This not only curbs adoption but also results in below average returns on investment in IT. Justifying the expenditure on advanced technologies poses a challenge for healthcare IT professionals. While on the one hand budget approvals require them to showcase achievements, on the other hand, achievements require a threshold amount of investment which needs to be approved by senior management.

Moreover, benefits such as reduction in medical error or improvements in patient outcomes cannot be measured in monetary terms. This makes it difficult to estimate the amount of expenditure required to accomplish a certain non-financial return.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs